N. S. Kokanov, “Variability of the HCV core region and host genetic and epigenetic factors can predict the response to pegylated interferon/ribavirin therapy in genotype 1b hepatitis C patients from Serbia”, Arch Biol Sci, vol. 75, no. 3, pp. 251–262, Oct. 2023.